4//SEC Filing
Papapetropoulos Spyros 4
Accession 0000899243-22-036831
CIK 0001827087other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 9:45 PM ET
Size
13.9 KB
Accession
0000899243-22-036831
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-11-18$14.00/sh−300$4,200→ 4,000 total - Exercise/Conversion
Stock Option Grant (Right to Buy)
2022-11-18−300→ 149,604 totalExercise: $1.89Exp: 2030-11-18→ Common Stock (300 underlying) - Exercise/Conversion
Common Stock
2022-11-18$1.89/sh+300$567→ 4,300 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022.
- [F2]25% of the shares subject to this option vested and became exercisable on September 14, 2021, with the remainder vesting in 36 equal monthly installments thereafter.
Issuer
Vigil Neuroscience, Inc.
CIK 0001827087
Entity typeother
Related Parties
1- filerCIK 0001832694
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 9:45 PM ET
- Size
- 13.9 KB